FDA Issues Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products and Devices | McDermott Will & Emery

Over the past few years, the life sciences and healthcare industries have experienced a notable increase in focus and interest in decentralized clinical trials (DCTs), in which some or...

Related Keywords

,Digital Health Technologies ,Software Used In Conducting Dcts ,National Institution Of Standards ,Mcdermott Will ,Drug Administrations ,Clinical Trials During ,Decentralized Clinical Trials ,Biological Products ,Draft Guidance ,Drug Omnibus Reform Act ,Remote Data Acquisition ,Clinical Investigations ,Clinical Trial Visits ,Clinical Trial Related ,National Institution ,Special Publication ,Identity Proofing Requirements ,Drug User Fee Act ,Shipping Investigational ,Federal Food ,Cosmetic Act ,